Venture Visionary Partners LLC Charles River Laboratories International, Inc. Transaction History

Venture Visionary Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$164.52 - $238.84 $62,682 - $90,998	-381 Reduced 11.09%	3,053 $721,000
Q3 2023 Oct 13, 2023	SELL	$194.44 - $217.61 $231,189 - $258,738	-1,189 Reduced 25.72%	3,434 $672,000
Q2 2023 Jul 14, 2023	BUY	$183.71 - $210.25 $367 - $420	2 Added 0.04%	4,623 $971,000
Q1 2023 Apr 13, 2023	BUY	$191.89 - $259.92 $232,570 - $315,023	1,212 Added 35.55%	4,621 $932,000
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $671,947 - $852,488	3,409 New	3,409 $742,000
Q2 2022 Jul 26, 2022	BUY	$204.13 - $302.4 $109,413 - $162,086	536 New	536 $114,000
Q1 2022 May 03, 2022	SELL	$255.51 - $362.11 $141,297 - $200,246	-553 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$351.38 - $448.68 $3,162 - $4,038	9 Added 1.65%	553 $208,000
Q3 2021 Oct 20, 2021	BUY	$372.64 - $458.3 $202,716 - $249,315	544 New	544 $224,000

710

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.